Shailesh Siroya has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shailesh Siroya, a promoter/substantial shareholder of Bal Pharma Limited, has submitted a declaration to the exchanges confirming that he has not created any encumbrance (pledge or charge) on his shareholding in the company during the financial year ended 31 March 2026. This filing is a routine compliance requirement under SEBI regulations for promoters to disclose their pledge status periodically. The declaration covers both direct and indirect shareholding.
A no-encumbrance declaration is generally viewed positively by investors as it indicates the promoter has not leveraged their shares for loans, reducing risk for minority shareholders. No immediate impact on stock price expected from this routine disclosure.